Peter M. Castleman - Jun 17, 2025 Form 3 Insider Report for Caris Life Sciences, Inc. (CAI)

Role
Director
Signature
/s/ J. Russel Denton, Attorney-in-Fact
Stock symbol
CAI
Transactions as of
Jun 17, 2025
Transactions value $
$0
Form type
3
Date filed
6/17/2025, 09:32 PM
Previous filing
Jun 23, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CASTLEMAN PETER M Director C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton, Attorney-in-Fact 2025-06-17 0001239594

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CAI Common Stock 16.1K Jun 17, 2025 Direct F1
holding CAI Common Stock 100K Jun 17, 2025 By Family Trust
holding CAI Common Stock 25K Jun 17, 2025 By CLS-PF-SPE, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CAI Stock Option Jun 17, 2025 Common Stock 2.5K $18.60 Direct F3
holding CAI Series A Preferred Stock Jun 17, 2025 Common Stock 10.2M $0.00 By CLS-PF-SPE, LLC F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 16,129 shares of Common Stock underlying restricted stock units which vest in accordance with the applicable grant agreement.
F2 CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F3 The stock option is fully vested and exercisable.
F4 Each share of preferred stock will automatically convert into 0.25 shares of Common Stock of the Issuer, subject to adjustment in accordance with the certificate of formation, upon the closing of the initial public offering of the Issuer's Common Stock.

Remarks:

Exhibit 24 - Power of Attorney.